EpiPen and EpiPen Junior will be subject to limited availability for the remainder of 2018. Mylan are now out of stock of EpiPen Junior and interruptions in the supply are anticipated to continue for the coming months.
This alert provides details of actions to take around the prescribing, dispensing and administration of adrenaline auto-injectors.
Whilst the deadline for completing the actions is the end of this year, we expect organisations to begin following the actions immediately upon receipt of this alert.